Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 24 | Ambrx Biopharma | Common Stock | Sale back to company | Dispose D | No | No | 0 | 22,936 | 0.00 | 0 |
7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 16.66 | 55,571 | 925.81 k | 0 |
7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 1.96 | 60,714 | 119.00 k | 0 |
7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 1.96 | 121,427 | 238.00 k | 0 |
7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 1.96 | 367,799 | 720.89 k | 0 |
7 Mar 24 | Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 50,000 | 0.00 | 0 |
7 Mar 24 | Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 107,143 | 0.00 | 0 |
5 Mar 24 | MOTS Motus GI | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 0.622 | 23,205 | 14.43 k | 23,205 |
11 Dec 23 | Ambrx Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 545,776 |
27 Oct 23 | Ambrx Biopharma | Common Stock | Sell | Dispose S | No | Yes | 9.82 | 12,778 | 125.48 k | 130,079 |